by Richard Daverman, PhD
April 19, 2013 -- Wuhan Kindstar Diagnostics, a company that provides esoteric testing services to over 3,300 China hospitals, has formed a collaboration with Illumina. Using Illumina’s TruSightTM content sets, Infinium® Dx CytoSNP-12 assay and NuPCRTM reagents, Kindstar will validate and implement molecular assays in its laboratories. Kindstar officials said the collaboration will expand its test offerings. More details...
Stock Symbol: (NSDQ: ILMN)
